Cagrilintide/Semaglutide, is a combination of cagrilintide, a dual amylin and calcitonin receptor agonist, and semaglutide, a GLP-1 agonist. It has been proposed as a follow-on to Ozempic, Mounjaro, and Wegovy in obesity and Type II diabetes treatment.
Ultima-Cagri+Sema Blend 5mg+5mg
Price range: $210.00 through $1,680.00
CLASSIFICATION Amylin receptor agonist / GLP-1 receptor agonist
MANUFACTURER Ultima Peptides – US
WAREHOUSE USA Warehouse 4
SUBSTANCE
Semaglutide,
Cagrilintide,




Reviews
There are no reviews yet.